James C. Mullen
2009
In 2009, James C. Mullen earned a total compensation of $10.4M as Former President and CEO at Biogen, a 8% decrease compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $163,340 |
|---|---|
| Non-Equity Incentive Plan | $1,440,000 |
| Option Awards | $2,379,233 |
| Salary | $1,204,615 |
| Stock Awards | $4,999,901 |
| Other | $253,077 |
| Total | $10,440,166 |
Mullen received $5M in stock awards, accounting for 48% of the total pay in 2009.
Mullen also received $163.3K of change in pension value and nonqualified deferred compensation earnings, $1.4M in non-equity incentive plan, $2.4M in option awards, $1.2M in salary and $253.1K in other compensation.
Rankings
In 2009, James C. Mullen's compensation ranked 197th out of 9,885 executives tracked by ExecPay. In other words, Mullen earned more than 98.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 197 out of 9,885 | 98th |
Division Manufacturing | 65 out of 3,690 | 98th |
Major group Chemicals And Allied Products | 15 out of 866 | 98th |
Industry group Drugs | 14 out of 638 | 98th |
Industry Biological Products, Except Diagnostic Substances | 2 out of 133 | 99th |
Source: SEC filing on April 21, 2011.
Mullen's colleagues
We found five more compensation records of executives who worked with James C. Mullen at Biogen in 2009.